Lim YT, Williams TC, Langley RJ, Weir E, et al. Mepolizumab in children and adolescents with severe eosinophilic asthma not eligible for Omalizumab: a single centre experience. J Asthma 2024 Jan 19:1-10. doi: 10.1080/02770903.2024.2303767.
PMID: 38240489